The evolving management of postoperative Crohn’s disease

References

• D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114(2), 262–267 (1998).
   PubMed Web of Science ®Google Scholar
• Bouguen G, Peyrin-Biroulet L. Surgery for adult Crohn’s disease: what is the actual risk? Gut 60(9), 1178–1181 (2011).
   PubMed Web of Science ®Google Scholar
• Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn’s disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 59(9), 1200–1206 (2010).
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn’s disease. Gut 60(7), 930–936 (2011).
   PubMed Web of Science ®Google Scholar
• Sachar DB. The problem of postoperative recurrence of Crohn’s disease. Med. Clin. North Am. 74(1), 183–188 (1990).
   PubMed Web of Science ®Google Scholar
• Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 54(2), 237–241 (2005).
   PubMed Web of Science ®Google Scholar
• Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn’s disease. Ann. Surg. 231(1), 38–45 (2000).
   PubMed Web of Science ®Google Scholar
• Katz JA. Postoperative endoscopic surveillance in Crohn’s disease: bottom up or top down? Gastrointest. Endosc. 66(3), 541–543 (2007).
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Feagan BG. The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn’s disease remains uncertain. Gastroenterology 127(3), 990–993 (2004).
   PubMed Web of Science ®Google Scholar
• Ng SC, Kamm MA. Management of postoperative Crohn’s disease. Am. J. Gastroenterol. 103(4), 1029–1035 (2008).
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Loftus EV Jr, Ng SC, Lakatos PL, Moum B; Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD). Hospitalisations and surgery in Crohn’s disease. Gut 61(4), 622–629 (2012).
   PubMed Web of Science ®Google Scholar
• Olaison G, Smedh K, Sjödahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 33(3), 331–335 (1992).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99(4), 956–963 (1990).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P. Review article: recurrence of Crohn’s disease after surgery – the need for treatment of new lesions. Aliment. Pharmacol. Ther. 24(Suppl. 3), 29–32 (2006).
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Lachman P, Sachar DB et al. Perforating and non-perforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. Gut 29(5), 588–592 (1988).
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn’s disease. Gastroenterology 115(2), 259–267 (1998).
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Korelitz BI, Rutgeerts P et al. Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 127(3), 723–729 (2004).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Goboes K, Peeters M et al. Effect of faecal stream diversion on recurrence of Crohn’s disease in the neoterminal ileum. Lancet 338(8770), 771–774 (1991).
   PubMed Web of Science ®Google Scholar
• Cameron JL, Hamilton SR, Coleman J, Sitzmann JV, Bayless TM. Patterns of ileal recurrence in Crohn’s disease. A prospective randomized study. Ann. Surg. 215(5), 546–551; discussion 551 (1992).
   PubMed Web of Science ®Google Scholar
• Cottone M, Orlando A, Modesto I. Postoperative maintenance therapy for inflammatory bowel disease. Curr. Opin. Gastroenterol. 22(4), 377–381 (2006).
   PubMed Web of Science ®Google Scholar
• Blum E, Katz JA. Postoperative therapy for Crohn’s disease. Inflamm. Bowel Dis. 15(3), 463–472 (2009).
   PubMed Web of Science ®Google Scholar
• Pascua M, Su C, Lewis JD, Brensinger C, Lichtenstein GR. Meta-analysis: factors predicting post-operative recurrence with placebo therapy in patients with Crohn’s disease. Aliment. Pharmacol. Ther. 28(5), 545–556 (2008).
   PubMed Web of Science ®Google Scholar
• Mekhjian HS, Switz DM, Watts HD, Deren JJ, Katon RM, Beman FM. National Cooperative Crohn’s Disease Study: factors determining recurrence of Crohn’s disease after surgery. Gastroenterology 77(4 Pt 2), 907–913 (1979).
   PubMed Web of Science ®Google Scholar
• McLeod RS, Wolff BG, Steinhart AH et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. Gastroenterology 109(2), 404–413 (1995).
   PubMed Web of Science ®Google Scholar
• Scarpa M, D’Incà R, Basso D et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn’s disease. Dis. Colon Rectum 50(6), 861–869 (2007).
   PubMed Web of Science ®Google Scholar
• Calabrese E, Petruzziello C, Onali S et al. Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings. Inflamm. Bowel Dis. 15(11), 1635–1642 (2009).
   PubMed Web of Science ®Google Scholar
• Bourreille A, Jarry M, D’Halluin PN et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study. Gut 55(7), 978–983 (2006).
   PubMed Web of Science ®Google Scholar
• Biancone L, Calabrese E, Petruzziello C et al. Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn’s disease. Inflamm. Bowel Dis. 13(10), 1256–1265 (2007).
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Defranchis R, Seidman E, Leighton JA, Legnani P, Lewis BS. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment. Pharmacol. Ther. 27(2), 146–154 (2008).
   PubMed Web of Science ®Google Scholar
• Cheifetz AS, Kornbluth AA, Legnani P et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn’s disease. Am. J. Gastroenterol. 101(10), 2218–2222 (2006).
   PubMed Web of Science ®Google Scholar
• El-Hachem S, Regueiro M. Postoperative Crohn’s disease: prevention and treatment. Expert Rev. Gastroenterol. Hepatol. 3(3), 249–256 (2009).
   PubMedGoogle Scholar
• Swoger JM, Regueiro M. Postoperative Crohn’s disease: how can we prevent it? Expert Rev. Clin. Immunol. 6(4), 501–504 (2010).
   PubMed Web of Science ®Google Scholar
• Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment. Pharmacol. Ther. 35(6), 625–633 (2012).
   PubMed Web of Science ®Google Scholar
• Terdiman JP. Prevention of postoperative recurrence in Crohn’s disease. Clin. Gastroenterol. Hepatol. 6(6), 616–620 (2008).
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Factors affecting recurrence after surgery for Crohn’s disease. World J. Gastroenterol. 11(26), 3971–3979 (2005).
   PubMed Web of Science ®Google Scholar
• Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J. Clin. Gastroenterol. 39(1), 32–35 (2005).
   PubMed Web of Science ®Google Scholar
• Avidan B, Sakhnini E, Lahat A et al. Risk factors regarding the need for a second operation in patients with Crohn’s disease. Digestion 72(4), 248–253 (2005).
   PubMed Web of Science ®Google Scholar
• Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn’s disease. Gastroenterology 98(5 Pt 1), 1123–1128 (1990).
   PubMed Web of Science ®Google Scholar
• Cottone M, Rosselli M, Orlando A et al. Smoking habits and recurrence in Crohn’s disease. Gastroenterology 106(3), 643–648 (1994).
   PubMed Web of Science ®Google Scholar
• Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int. J. Colorectal Dis. 23(12), 1213–1221 (2008).
   PubMed Web of Science ®Google Scholar
• Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 110(2), 424–431 (1996).
   PubMed Web of Science ®Google Scholar
• Simillis C, Yamamoto T, Reese GE et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am. J. Gastroenterol. 103(1), 196–205 (2008).
   PubMed Web of Science ®Google Scholar
• Sachar DB, Lemmer E, Ibrahim C et al. Recurrence patterns after first resection for stricturing or penetrating Crohn’s disease. Inflamm. Bowel Dis. 15(7), 1071–1075 (2009).
   PubMed Web of Science ®Google Scholar
• Poggioli G, Laureti S, Selleri S et al. Factors affecting recurrence in Crohn’s disease. Results of a prospective audit. Int. J. Colorectal Dis. 11(6), 294–298 (1996).
   PubMed Web of Science ®Google Scholar
• Chardavoyne R, Flint GW, Pollack S, Wise L. Factors affecting recurrence following resection for Crohn’s disease. Dis. Colon Rectum 29(8), 495–502 (1986).
   PubMed Web of Science ®Google Scholar
• Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn’s disease. Experience with 1379 patients. Ann. Surg. 214(3), 230>–238; discussion 238 (1991).
   PubMed Web of Science ®Google Scholar
• Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A. Prognostic factors for postoperative recurrence of Crohn’s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis. Colon Rectum 39(3), 335–341 (1996).
   PubMed Web of Science ®Google Scholar
• Unkart JT, Anderson L, Li E et al. Risk factors for surgical recurrence after ileocolic resection of Crohn’s disease. Dis. Colon Rectum 51(8), 1211–1216 (2008).
   PubMed Web of Science ®Google Scholar
• Ewe K, Herfarth C, Malchow H, Jesdinsky HJ. Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. Digestion 42(4), 224–232 (1989).
   PubMed Web of Science ®Google Scholar
• Scarpa M, Ruffolo C, Bertin E et al. Surgical predictors of recurrence of Crohn’s disease after ileocolonic resection. Int. J. Colorectal Dis. 22(9), 1061–1069 (2007).
   PubMed Web of Science ®Google Scholar
• Bergamaschi R, Pessaux P, Arnaud JP. Comparison of conventional and laparoscopic ileocolic resection for Crohn’s disease. Dis. Colon Rectum 46(8), 1129–1133 (2003).
   PubMed Web of Science ®Google Scholar
• Simillis C, Jacovides M, Reese GE, Yamamoto T, Tekkis PP. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis. Colon Rectum 53(2), 177–185 (2010).
   PubMed Web of Science ®Google Scholar
• Simillis C, Purkayastha S, Yamamoto T, Strong SA, Darzi AW, Tekkis PP. A meta-analysis comparing conventional end-to-end anastomosis vs. other anastomotic configurations after resection in Crohn’s disease. Dis. Colon Rectum 50(10), 1674–1687 (2007).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Bain IM, Mylonakis E, Allan RN, Keighley MR. Stapled functional end-to-end anastomosis versus sutured end-to-end anastomosis after ileocolonic resection in Crohn disease. Scand. J. Gastroenterol. 34(7), 708–713 (1999).
   PubMed Web of Science ®Google Scholar
• Regueiro M. Management and prevention of postoperative Crohn’s disease. Inflamm. Bowel Dis. 15(10), 1583–1590 (2009).
   PubMed Web of Science ®Google Scholar
• Yoshida K, Fukunaga K, Ikeuchi H et al. Scheduled infliximab monotherapy to prevent recurrence of Crohn’s disease following ileocolic or ileal resection: a 3-year prospective randomized open trial. Inflamm. Bowel Dis. 18(9) 1617–1623 (2011).
   PubMed Web of Science ®Google Scholar
• Schwartz M, Regueiro M. Prevention and treatment of postoperative Crohn’s disease recurrence: an update for a new decade. Curr. Gastroenterol. Rep. 13(1), 95–100 (2011).
   PubMedGoogle Scholar
• Marteau P, Lémann M, Seksik P et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial. Gut 55(6), 842–847 (2006).
   PubMed Web of Science ®Google Scholar
• Van Gossum A, Dewit O, Louis E et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii LA1) on early endoscopic recurrence of Crohn’s disease after lleo-caecal resection. Inflamm. Bowel Dis. 13(2), 135–142 (2007).
   PubMed Web of Science ®Google Scholar
• Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut 51(3), 405–409 (2002).
   PubMed Web of Science ®Google Scholar
• Chermesh I, Tamir A, Reshef R et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn’s disease. Dig. Dis. Sci. 52(2), 385–389 (2007).
   PubMed Web of Science ®Google Scholar
• Hellers G, Cortot A, Jewell D et al. Oral budesonide for prevention of postsurgical recurrence in Crohn’s disease. The IOIBD Budesonide Study Group. Gastroenterology 116(2), 294–300 (1999).
   PubMed Web of Science ®Google Scholar
• Ewe K, Böttger T, Buhr HJ, Ecker KW, Otto HF. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn’s disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group. Eur. J. Gastroenterol. Hepatol. 11(3), 277–282 (1999).
   PubMed Web of Science ®Google Scholar
• Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst. Rev. 4, CD000301 (2003).
   Google Scholar
• Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. Gastroenterology 108(6), 1617–1621 (1995).
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Van Assche G, Vermeire S et al. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 128(4), 856–861 (2005).
   PubMed Web of Science ®Google Scholar
• Lémann M. Review article: can post-operative recurrence in Crohn’s disease be prevented? Aliment. Pharmacol. Ther. 24(Suppl. 3), 22–28 (2006).
   PubMed Web of Science ®Google Scholar
• Caprilli R, Cottone M, Tonelli F et al. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn’s disease: a pragmatic, double-blind, randomized controlled trial. Aliment. Pharmacol. Ther. 17(4), 517–523 (2003).
   PubMed Web of Science ®Google Scholar
• Cottone M, Cammà C. Mesalamine and relapse prevention in Crohn’s disease. Gastroenterology 119(2), 597 (2000).
   PubMed Web of Science ®Google Scholar
• Sutherland LR, Martin F, Bailey RJ et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn’s disease. The Canadian Mesalamine for Remission of Crohn’s Disease Study Group. Gastroenterology 112(4), 1069–1077 (1997).
   PubMed Web of Science ®Google Scholar
• Florent C, Cortot A, Quandale P et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn’s disease. Groupe d’Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Eur. J. Gastroenterol. Hepatol. 8(3), 229–233 (1996).
   PubMed Web of Science ®Google Scholar
• Wenckert A, Kristensen M, Eklund AE et al. The long-term prophylactic effect of salazosulphapyridine (Salazopyrin) in primarily resected patients with Crohn’s disease. A controlled double-blind trial. Scand. J. Gastroenterol. 13(2), 161–167 (1978).
   PubMed Web of Science ®Google Scholar
• Summers RW, Switz DM, Sessions JT Jr et al. National Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterology 77(4 Pt 2), 847–869 (1979).
   PubMed Web of Science ®Google Scholar
• Lochs H, Mayer M, Fleig WE et al. Prophylaxis of postoperative relapse in Crohn’s disease with mesalamine: European Cooperative Crohn’s Disease Study VI. Gastroenterology 118(2), 264–273 (2000).
   PubMed Web of Science ®Google Scholar
• Brignola C, Cottone M, Pera A et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn’s disease. Italian Cooperative Study Group. Gastroenterology 108(2), 345–349 (1995).
   PubMed Web of Science ®Google Scholar
• Caprilli R, Andreoli A, Capurso L et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn’s disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment. Pharmacol. Ther. 8(1), 35–43 (1994).
   PubMed Web of Science ®Google Scholar
• Ford AC, Khan KJ, Talley NJ, Moayyedi P. 5-aminosalicylates prevent relapse of Crohn’s disease after surgically induced remission: systematic review and meta-analysis. Am. J. Gastroenterol. 106(3), 413–420 (2011).
   PubMed Web of Science ®Google Scholar
• Sandborn W, Sutherland L, Pearson D et al. Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane Database Syst. Rev. 2, CD000545 (2000).
   Google Scholar
• Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintaining remission of Crohn’s disease. Cochrane Database Syst. Rev. 2, CD000067 (2000).
   Google Scholar
• Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann. Intern. Med. 123(2), 132–142 (1995).
   PubMed Web of Science ®Google Scholar
• Domènech E, Mañosa M, Bernal I et al. Impact of azathioprine on the prevention of postoperative Crohn’s disease recurrence: results of a prospective, observational, long-term follow-up study. Inflamm. Bowel Dis. 14(4), 508–513 (2008).
   PubMed Web of Science ®Google Scholar
• Ardizzone S, Maconi G, Sampietro GM et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology 127(3), 730–740 (2004).
   PubMed Web of Science ®Google Scholar
• D’Haens GR, Vermeire S, Van Assche G et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial. Gastroenterology 135(4), 1123–1129 (2008).
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Deltenre P, Ardizzone S et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am. J. Gastroenterol. 104(8), 2089–2096 (2009).
   PubMed Web of Science ®Google Scholar
• Regueiro M, Schraut W, Baidoo L et al. Infliximab prevents Crohn’s disease recurrence after ileal resection. Gastroenterology 136(2), 441–450.e1; quiz 716 (2009).
   PubMed Web of Science ®Google Scholar
• Savarino E, Dulbecco P, Bodini G, Assandri L, Savarino V. Prevention of postoperative recurrence of Crohn’s disease by adalimumab: a case series. Eur. J. Gastroenterol. Hepatol. 24(4), 468–470 (2012).
   PubMed Web of Science ®Google Scholar
• Sorrentino D, Terrosu G, Avellini C, Maiero S. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch. Intern. Med. 167(16), 1804–1807 (2007).
   PubMedGoogle Scholar
• Scimeca D, Mocciaro F, Cottone M et al. Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn’s disease strictures. Dig. Liver Dis. 43(2), 121–125 (2011).
   PubMedGoogle Scholar
• Breysem Y, Janssens JF, Coremans G, Vantrappen G, Hendrickx G, Rutgeerts P. Endoscopic balloon dilation of colonic and ileo-colonic Crohn’s strictures: long-term results. Gastrointest. Endosc. 38(2), 142–147 (1992).
   PubMed Web of Science ®Google Scholar
• Morini S, Hassan C, Lorenzetti R et al. Long-term outcome of endoscopic pneumatic dilatation in Crohn’s disease. Dig. Liver Dis. 35(12), 893–897 (2003).
   PubMedGoogle Scholar
• Blomberg B, Rolny P, Järnerot G. Endoscopic treatment of anastomotic strictures in Crohn’s disease. Endoscopy 23(4), 195–198 (1991).
   PubMed Web of Science ®Google Scholar
• De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV. Postoperative recurrent luminal Crohn’s disease: a systematic review. Inflamm. Bowel Dis. 18(4), 758–777 (2012).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Umegae S, Matsumoto K. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn’s disease: a prospective pilot study. Inflamm. Bowel Dis. 15(10), 1460–1466 (2009).
   PubMed Web of Science ®Google Scholar
• Sorrentino D, Terrosu G, Paviotti A et al. Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn’s disease: partial benefit by infliximab – a pilot study. Dig. Dis. Sci. 57(5), 1341–1348 (2012).
   PubMed Web of Science ®Google Scholar
• Herfarth H, Tjaden C, Lukas M et al.; Z T-1 Study Group. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn’s disease. Gut 55(10), 1525–1526 (2006).
   PubMed Web of Science ®Google Scholar
• Fernández-Blanco I, Monturiol J, Martinez B, Cara C, Taxonera C. Adalimumab in the prevention of postoperative recurrence of Crohn’s disease. Gastroenterology 138(5 Suppl. 1), S–692 (2010).
   Google Scholar
• Mantzaris GJ, Petraki K, Archavlis EJ et al. Pilot study of adalimumab for early prevention and/or treatment of post-operative endoscopic recurrence of Crohn’s Disease. Gastroenterology 140(5), S–275 (2011).
   PubMed Web of Science ®Google Scholar
• Cho SM, Cho SW, Regueiro M. Postoperative management of Crohn disease. Med. Clin. North Am. 94(1), 179–188 (2010).
   PubMed Web of Science ®Google Scholar